홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Rosiglitazone → Pioglitazone, (R)-

HRID 882707
인쇄

반응식

HRID 882707 반응식
[CH2:1]([C:3]1[CH:4]=[CH:5][C:6]([CH2:9][CH2:10][O:11][C:12]2[CH:17]=[CH:16][C:15](/[CH:18]=[C:19]3\[C:20](=[O:25])[NH:21][C:22](=[O:24])[S:23]\3)=[CH:14][CH:13]=2)=[N:7][CH:8]=1)[CH3:2].CN(C1C=CC=CN=1)CCOC1C=CC(CC2SC(=O)NC2=O)=CC=1>>[CH2:1]([C:3]1[CH:4]=[CH:5][C:6]([CH2:9][CH2:10][O:11][C:12]2[CH:17]=[CH:16][C:15]([CH2:18][C@H:19]3[S:23][C:22](=[O:24])[NH:21][C:20]3=[O:25])=[CH:14][CH:13]=2)=[N:7][CH:8]=1)[CH3:2]
참가 물질실험 절차출처 및 근거반응 노트

참가 물질

3

반응물 2

HCID 77999RosiglitazoneHCID 14211277(E)-5-(4-(2-(5-ethylpyridin-2-yl)ethoxy)benzylidene)thiazolidine-2,4-dione

생성물 1

HCID 29010894Pioglitazone, (R)-

실험 절차

Biocatalytic reduction of 5-[1-{4-[2-(5-ethyl-pyridin-2-yl)-ethoxy]-phenyl}-meth-(E)-ylidene]-thiazolidine-2,4-dione was investigated using literature procedures described for Rosiglitazone (J. Chem. Soc. Perkin Trans. I, 1994, 3319-3324).

출처 및 근거

ORD 기록
ord-a1d64ffa47914ff0add7c2fa22c7cfca
출처 데이터셋
uspto-grants-2012_08
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08236786B2

반응 노트

이 페이지에서참가 물질실험 절차출처 및 근거반응 노트